lumicain Topical Hemostatic Solution

LUMICAIN- aluminium chloride hexahydrate solution
Medical Products Laboratories, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

FOR TOPICAL APPLICATION ONLY

For Granulation Tissue Growth: Allow packing saturated in Lumicain to remain in nail groove for 48 hours; repeat if necessary.

If hemmorrhage is profuse, dress wound with gauze saturated with Lumicain and allow to remain for 24 hours or longer.

CAUTION: Federal Law restricts sale and use to physician or licensed practitioner.

lbl premier lumicain TM Topical Hemostatic Solution 60cc

For Rapid Control of Minor Hemorrhage

Each Gram Contains: Aluminium Chloride............250 mg.

In an aqueous base.

Enter section text here

LUMICAIN
aluminium chloride hexahydrate solution

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ALUMINUM CHLORIDE (UNII: 3CYT62D3GA) (ALUMINUM CATION - UNII:3XHB1D032B)	ALUMINUM CHLORIDE	250 mg in 1 g

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:10733-412-60	67 g in 1 BOTTLE; Type 0: Not a Combination Product	09/29/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
unapproved drug other		09/29/2010

Labeler - Medical Products Laboratories, Inc. (002290302)

Registrant - Medical Products Laboratories, Inc. (002290302)

Name	Address	ID/FEI	Business Operations
Establishment
Medical Products Laboratories, Inc.		002290302	analysis(10733-412) , manufacture(10733-412) , label(10733-412) , pack(10733-412)